SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

AARTI DRUGS

BSE: 524348 28 Jun 2025
Healthcare
₹ 432.5
Aarti Drugs Limited specializes in Pharmaceuticals within the Healthcare sector.

AARTI DRUGS - Share Price & Details

Market Cap
₹4,051
High /Low
635.0 / 312.0
Stock P/E
24.1
Book Value
₹149.0
Dividend Yield
0.23
ROCE
12.9
ROE
₹12.7
Face Value
10.0
PEG Ratio
6.0
EVEBITDA
₹15.4
Debt
615
CMP / FCF
71.9
Debt to equity
₹0.45
NP Ann
168
High price all time
1,027
Piotroski score
₹4.0
Graham Number
248.0
No. Eq. Shares
9.19
Net CF
₹-2.17
Net profit
168
Price to book value
2.96
Interest Coverage
₹6.9
Low price all time
3.81
Industry PE
32.0
Reserves
₹1,278
Free Cash Flow
₹67.5

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
AARTI DRUGS LTD.6246.7614.86229.66.744,05124.1
RPG LIFE SCIENCES LTD.1481.51173.51430.90397134.4
Advanced Enzyme Technologies L917.36110.54872.060.99363627.7

Peer Comparison Chart


About AARTI DRUGS

Aarti Drugs Limited, with Security Code 524348, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Aarti Drugs Faces Mixed Technical Signals Amid Market Challenges and Volatility

(15 Jun 2025)
Aarti Drugs, a small-cap pharmaceutical company, has seen a slight stock price increase but a year-over-year decline. Despite mixed technical signals and...
Read more →

Is Aarti Drugs overvalued or undervalued?

(11 Jun 2025)
As of May 26, 2025, Aarti Drugs is considered undervalued with a PE ratio of 25.26 and a favorable valuation compared to peers like Sun Pharma and Divi's...
Read more →

The Worst Performing Mutual Funds: Mutual Fund

(11 Jun 2025)
The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up to 6,65000 equity shares of face value of Rs 10 each at a p...
Read more →

AARTIDRUGS Stock Price and Chart — NSE:AARTIDRUGS

(10 Jun 2025)
Aarti Drugs Ltd. engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India...
Read more →

Aarti Drugs Faces Significant Stock Decline Amid Mixed Market Performance Trends

(30 May 2025)
Aarti Drugs, a small-cap pharmaceutical company, saw a notable decline on May 30, 2025, following three days of gains.
Read more →

AARTI DRUGS Share Price Today Up 6%

(20 May 2025)
Real-time updates on AARTI DRUGS share price. Check out the detailed analysis of the company in this live blog.
Read more →